FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
How a national blood shortage could impact people with sickle cell disease
How a national blood shortage could impact people with sickle cell disease
Kenya sickle cell: Fighting to dispel the myths around the disease
Kenya sickle cell: Fighting to dispel the myths around the disease